Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps

Plastic and Reconstructive Surgery

Volumn 110, Issue 1, 2002, Pages 149-159

  Lubiatowski, Przemyslaw ^a,b,c   Gurunluoglu, Raffi ^a,b,c   Goldman, Corey K ^a,b,c   Skugor, Blaazenka ^a,b,c   Carnevale, Kevin ^a,b,c   Siemionow, Maria ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b The Kosciuszko Foundation Inc   (United States)

^c Watson Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CAPILLARY PERMEABILITY; CONTROLLED STUDY; CREMASTER MUSCLE; DRUG EFFECT; GENE THERAPY; HISTOLOGY; INFLAMMATION; MALE; MUSCLE FLAP; MUSCLE PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULITIS; VIRAL GENE DELIVERY SYSTEM;

EID: 0036292714     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200207000-00026     Document Type: Article

References (35)

1. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
2. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis
3. Therapeutic angiogenesis
4. Isolation of angiopoietin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning
5. Angiopoietin-1 protects the adult vasculature against plasma leakage
6. Leaky vessels? Call ang-1
7. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
8. Vascular-specific growth factors and blood vessel formation
9. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
10. Dominant negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
11. Requiste te role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis
12. Cardivascular gene therapy
13. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
14. Vascular isolation of the rat cremaster muscle
15. Direct in vivo observation of embolic events in the microcirculation distal to a small-vessel anastomosis
16. Effect of muscle flap denervation on flow hemodynamics: A new model for chronic in vivo studies
17. Adenovirus-mediated gene transfer into normal arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia
18. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
19. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121
20. Adeno-associated virus-mediated vascular endothelial growth factor gene transfer into cardiac myocytes
21. Efficient expression of vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector
22. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion
23. Six-month assessment of phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF 121 cDNA
24. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
25. Clinical applications of research on angiogenesis
26. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat
27. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat
28. The effects of VEGF on survival of a random flap in the rat: Examination of various routes of administration
29. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor
30. Effect of time on the viability of ischemic skin flaps treated with vascular endothelial growth factor (VEGF) cDNA
31. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps
32. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
33. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
34. Chemotactic properties of angiopoietin-1 and 2, ligands for the endothelial-specific receptor tyrosine kinase Tie 2
35. TIE 1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth